Contribution: Industrial Research Assistance Program – Contributions to Firms
Vital Biosciences Inc
$71,500.00
Improving performance of novel, ultra-bright optical reporter particles for highly sensitive immunoassays
FY 2020-21 · 2021-02-09
Summary
The proposed development of standardized quality control and fabrication protocols for our proprietary optical reporter particles will reduce batch variability and non-specific interactions, establishing greater control over the performance of Vital Biosciences’ diagnostic assays. By the end of the proposed project, all fabrication protocols, quality control documentation, and internal validation with a representative immunoassay will be complete; this work will support utility in our full menu of in vitro diagnostics technologies.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
738751494
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-02-09 | 2020-21 | $71,500.00 |
| 1 | 2021-02-09 | 2020-21 | $71,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 31 jours.
Agreement End Date
2021-07-31
Agreement Number
965186
Agreement Start Date
2021-02-09
Agreement Title
Improving performance of novel, ultra-bright optical reporter particles for highly sensitive immunoassays
Agreement Title (French)
Améliorer les performances des nouvelles particules optiques rapporteuses ultra-lumineuses pour les essais immunologiques hautement sensibles
Agreement Type
Contribution
Agreement Value
$71,500.00
Amendment Date
2021-05-31
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The proposed development of standardized quality control and fabrication protocols for our proprietary optical reporter particles will reduce batch variability and non-specific interactions, establishing greater control over the performance of Vital Biosciences’ diagnostic assays. By the end of the proposed project, all fabrication protocols, quality control documentation, and internal validation with a representative immunoassay will be complete; this work will support utility in our full menu of in vitro diagnostics technologies.
Description (French)
L'élaboration proposée de protocoles normalisés de contrôle de la qualité et de fabrication de nos particules optiques rapporteuses exclusives permettra de réduire la variabilité des lots et les interactions non spécifiques, établissant ainsi un meilleur contrôle sur la performance des tests de diagnostic de Vital Biosciences. À la fin du projet proposé, tous les protocoles de fabrication, la documentation du contrôle de qualité et la validation interne avec un immunoessai représentatif seront terminés; ce travail sera utile dans notre menu complet de technologies de diagnostic in vitro.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Erin Mills
Federal Riding (French)
Mississauga--Erin Mills
Federal Riding Number
35060
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
738751494
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Vital Biosciences Inc
Recipient Postal Code
L5L 4L4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q4-965186
